MedTech I.Q.

The Cutting Edge of Medical Technology Content, Community & Collaboration

Adam Fleming
  • Male
  • Fremont, CA
  • United States
Share on Facebook Share on Facebook Share

Gifts Received


Adam Fleming has not received any gifts yet

Give a Gift


Adam Fleming's Page

Latest Activity

Adam Fleming posted blog posts
Adam Fleming posted blog posts
Adam Fleming posted blog posts
Feb 7
Adam Fleming posted events
Jan 6
Adam Fleming posted events
Dec 10, 2019
Adam Fleming posted a blog post

Pharmaceutical Drug Registration in China

Surely, no pharma company can overlook the world’s second largest pharmaceutical market: China. Its huge population has a high demand for healthcare products. In tune with this growing requirement, many changes have been brought in into the healthcare system, which is now more attractive than ever to foreign companies that want to bring in new products to market.On the one hand, factors such as incentives, such as market exclusivity and acceptance of foreign clinical trial data, are too good to…See More
Oct 9, 2019
Adam Fleming posted a blog post

Facts about deviation investigations everyone should know

Focus on how to avoid the pitfalls that may occur during FDA inspections and help eliminate 483 observations. Learn how to identify and avoid potential pitfalls during deviation investigations.One of the foremost common authority 483 and Warning Letter citations continues to be inadequate investigations. The authority uses the investigation reports and investigation trends to spot potential quality issues altogether areas of the corporate. Ultimately, inadequate investigations will result in…See More
Aug 12, 2019
Adam Fleming posted events
Jul 15, 2019
Adam Fleming posted an event

21 CFR Part 11 - Compliance for Electronic Records and Signatures at Online

June 26, 2019 from 10am to 11:30am
Overview: This Webinar will explain what 21 CFR Part 11 is, why it is important to FDA regulated companies and how conformance to Part 11 differs from just having good IT security. Procedures for controlling electronic signatures and electronic records as described in the FDA Guidance will be explained.FDA regulated companies want to transition to electronic records for economy and efficiency. FDA, because of its concern for patient safety, wants to prevent electronic records from being…See More
Jun 25, 2019
Adam Fleming posted events
May 20, 2019
Adam Fleming posted a blog post

FOOD SUPPLY CHAIN – An Incredibly Easy Method That Works For All

A few sciences are changing our lives in more ways than we could have imagined a few decades ago. Artificial Intelligence (AI) is at the forefront of these. Although a few decades old, it has received a huge boost of late with the emergence of the cloud, which is set to help it overcome one of its biggest stumbling blocks, namely space, the added power of computing, and wider methods of algorithms.While one would like to associate AI with robotics, this is taking a very limited view of a topic…See More
May 16, 2019

Profile Information

Area of Expertise or Interest?
Compliance4All has experts who share a wealth of knowledge covering best practices in industry. These trainings help participants refresh their knowledge about regulatory compliance. Our panel of Experts imparts learning on a number of areas relating to compliance, such as:

Medical Devices
PCI industries, and

Our webinars cover the following Governing Areas:

GxP (Manufacturing/Clinical/Lab)
SOX and

These are the functional areas Experts from Compliance4All offer their expertise on:

Clinical Trials, and
Type of Affiliation?
Academia or NonProfit
Years of Experience in MedTech Field
About Me
Compliance4All, the ultimate continuing professional education provider offers you regulatory and compliance trainings from the industry's leading experts, but with one crucial difference -the cost. Compliance4All's objective is to be a platform that provides regulatory and compliance trainings with all the class and features that come with these trainings, at a lower price. Compliance4All seeks to make regulatory and compliance trainings low-hanging fruits.
Professional Objectives
Compliance4All's objective is to be a platform that provides regulatory and compliance trainings with all the class and features that come with these trainings, at a lower price. Compliance4All seeks to make regulatory and compliance trainings low-hanging fruits.

Adam Fleming's Blog

Writing Excellent SOPs

Posted on February 19, 2020 at 6:22am 0 Comments

Almost every paragraph of the Quality System Regulation states that manufacturers shall "establish" procedures.

Well written SOPs that are easy to understand and follow are necessary to accomplish that objective. Excellent SOPs need more than just subject matter.

This webinar will help you to write complete, clear, unambiguous, and flexible SOPs. You will learn techniques for creating concise and easy to read SOPs that your employees can understand and will follow. Well…


Implementing an Effective CAPA System

Posted on February 19, 2020 at 6:21am 0 Comments

CAPA, no matter how you look at it, is the heart of the quality management system. CAPA can be viewed as and is the merging of change control, continuous improvement, and complaint management.

What does the CAPA system do for the organization? CAPA not only indicates the organization's ability to respond to problems that arise but also to proactively anticipate and prevent subsequent problems from arising.

This webinar highlights the various regulations governing CAPAs, how…


Change Management System

Posted on February 19, 2020 at 6:16am 0 Comments

The presentation will focus on FDA responses to failures in Change Management.

The presentation shall describe how FDA expects firms to establish change management, the sources of change management, the outcomes from change management, and timely outcomes. We will cover some suggestions and Do's and Dont's.

3-Hour Virtual Seminar on FDA's section 804 Drug and 801(d)(1)(B) Biologic Importation Programs

Posted on February 19, 2020 at 6:15am 0 Comments

This presentation outlines the two proposed pathways through which HHS and FDA will allow for the importation of certain drugs originally intended for non-US markets.

Notably, both pathways rely on parties other than the federal government-such as states, wholesalers, pharmacists, and manufacturers-to demonstrate that eligible drugs can be imported into the US safely and with the required cost savings.

Comment Wall (1 comment)

You need to be a member of MedTech I.Q. to add comments!

Join MedTech I.Q.

At 8:47am on February 17, 2016, FRANK KWABENA said…

Good Day,

How is everything with you, I picked interest on you after going through your short profile and deemed it necessary to write you immediately. I have something very vital to disclose to you, but I found it difficult to express myself here, since it's a public site.Could you please get back to me on:( ) for the full details.

Have a nice day

Thanks God bless

mr frank.


© 2020   Created by CC-Conrad Clyburn-MedForeSight.   Powered by

Badges  |  Report an Issue  |  Terms of Service